Cancer sufferers repeatedly find help in treating cancer through marijuana
Glioma is an aggressive primary tumor of the central nervous system. Tumors arise from glial cells that provide protection, support and a dynamic state of equilibrium. Different researchers have proven that cannabis extract can slow the growth of brain tumors, as well as effectively combat all their symptoms. The plant proves once again why its use is ideal for a large number of patients.
Glioma is the most malignant brain tumor. Common symptoms include headache, vomiting, nausea and seizures. Preclinical studies recommend possible therapy with medical cannabis through inhibition of invasiveness, induction of tumor cell death (apoptosis) and inhibition of tumor proliferation and angiogenesis (formation of new blood vessels around a tissue).
Clinical studies have been conducted on patients with glioma to study the use of medical cannabis in this disease. Overall, users have reported pain relief, relief of nausea, stimulation of appetite, relief through relaxation, ability to cope with emotions, help with sleep and a decrease in seizures.
The treatments currently used to treat this type of cancer are chemotherapy, radiotherapy, and surgery, but none of these can ensure the patient’s recovery. Cannabidiol (CBD), however, seems to alter the tumor’s micro-ecosystem, also decreasing the level of local inflammation, which could be promising for use as a supplementary drug to ordinary therapies.
CBD was also shown to be effective in reducing the recruitment of glial cells by the tumor, which in its presence, often turn into glioblastoma-associated macrophages. It also helps to positively change the levels of molecules such as P-selectin, apelin, IL-8, IDO, CD103 or CD8.